In VCR-treated G1 phase ALL cells, olaparib may block AIF-mediated DNA fragmentation, but other DNA cleavage mechanisms may operate, such as that mediated by EndoG, which also undergoes nuclear translocation (Fig. 8E). This evidence concerns the gene ENDOG and acute lymphoblastic leukemia.